Keros Therapeutics, Inc. (KROS): SCHEDULE 13G/A filed Feb 17, 2026

Form type

SCHEDULE 13G/A

Filing date

Feb 17, 2026

Accession number

0000905148-26-000905

Filer

Keros Therapeutics, Inc. (CIK 1664710)